Leaderboards/acute kidney injury research

acute kidney injury research

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Dohui Kim
Pohang University of Science and Technology
99
2
Dong Sung Kim
Pohang University of Science and Technology
90
3
Qiang Zheng
Central South University
80
4
Dongshan Zhang
Central South University
70
5
Tianlong Li
Wuhan University
60
6
Mengqi Shi
South China University of Technology
40
7
Hong C. Shen
Roche (China)
30
8
Sandra M. Herrmann
Mayo Clinic
20
9
Abhijat Kitchlu
University Health Network
10

Rising Stars Papers

1
Assessment of GFR in Patients with Cancer
Clinical Journal of the American Society of Nephrology|2024
39 cit.
2
Macrophage migration inhibitory factor (MIF) suppresses mitophagy through disturbing the protein interaction of PINK1-Parkin in sepsis-associated acute kidney injury
Cell Death and Disease|2024
24 cit.
3
Discovery and verification of mmu_Circ_26986/hsa_Circ_0072463 as a potential biomarker and intervention target for sepsis-associated acute kidney injury
Cellular and Molecular Life Sciences|2024
15 cit.
4
The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
Stem Cell Research & Therapy|2024
10 cit.
5
Proximal tubular <scp>MBD2</scp> promotes autophagy to drive the progression of <scp>AKI</scp> caused by vancomycin via regulation of <scp>miR</scp> ‐597‐5p/ <scp>S1PR1</scp> axis
The FASEB Journal|2024
3 cit.
6
Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI
Journal of Inflammation Research|2024
3 cit.
7
PRDM16 suppresses pyroptosis to attenuate the progression of AKI caused by rhabdomyolysis via upregulation of USP10
Cellular and Molecular Life Sciences|2025
2 cit.
8
Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a potential biomarker and intervention target for ischemia reperfusion injury-induced AKI
Research Square|2024
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Adeera Levin
Providence Health Care
99
2
Yongming Chen
Guangdong Medical College
90
3
Chenning Li
Zhongshan Hospital
80
4
Junlong Hu
Soochow University
70
5
Andreas Baumbach
Queen Mary University of London
60
6
Jan Gunst
KU Leuven
40
7
Minyan Zhu
Renji Hospital
30
8
Matthieu Legrand
University of California, San Francisco
20
9
Vennela Avula
Johns Hopkins University
10

Emerging Leaders Papers

1
Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study
EClinicalMedicine|2024
184 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Patrick W. Serruys
Columbia University Irving Medical Center
99
2
Kai‐Uwe Eckardt
Friedrich-Alexander-Universität Erlangen-Nürnberg
90
3
Christoph Wanner
Universitätsklinikum Würzburg
80
4
Martin B. Leon
Erasmus MC
70
5
Chun Zhang
Union Hospital
60
6
Pearl L. H. Mok
Manchester Academic Health Science Centre
50
7
Jørn Wetterslev
Rigshospitalet
50
8
Zhiyong Peng
Wuhan University
50
9
Stuart L. Goldstein
Cincinnati Children's Hospital Medical Center
40
10
Simon C. Ling
Baylor College of Medicine
30

All-Time Leaders Papers

1
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
New England Journal of Medicine|2016
3.6k cit.
2
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
Journal of the American College of Cardiology|2021
1.2k cit.
3
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†
European Heart Journal|2012
1k cit.
4
Estimating required information size by quantifying diversity in random-effects model meta-analyses
BMC Medical Research Methodology|2009
960 cit.
5
Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document
Journal of Thoracic and Cardiovascular Surgery|2012
918 cit.
6
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
European Heart Journal|2020
817 cit.
7
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients
Nephrology Dialysis Transplantation|2004
69 cit.
8
Csf2 Attenuated Sepsis-Induced Acute Kidney Injury by Promoting Alternative Macrophage Transition
Frontiers in Immunology|2020
53 cit.
9
Merging virtual and physical experiences: extended realities in cardiovascular medicine
European Heart Journal|2023
51 cit.
10
MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
Journal of Cancer|2016
45 cit.

Reagents for acute kidney injury research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Cleaved-PARP (Asp214) (E2T4K) Mouse Monoclonal Antibody

Cited in 15 papers
#32563$179
View Evidence →Cell Signaling Technology

Phospho-MLKL (Ser345) (D6E3G) Rabbit Monoclonal Antibody

#37333$197
View Evidence →Cell Signaling Technology

COL1A1 (E8F4L) Rabbit Monoclonal Antibody

#72026$180
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

CD3 epsilon (D4V8L) Rabbit Monoclonal Antibody

#99940$166
View Evidence →Cell Signaling Technology

PKC-delta Antibody

Cited in 5 papers
#2058$317
View Evidence →Cell Signaling Technology

GDF15/MIC1 (E5Q8Q) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#70830$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Cleaved-PARP (Asp214) (E2T4K) Mouse Monoclonal Antibody

Cited in 15 papers
#32563$179
View Evidence →Cell Signaling Technology

Thy1/CD90 (D3V8A) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 7 papers
#16836$865
View Evidence →Cell Signaling Technology

Phospho-RCC1 (Ser11) Antibody

Cited in 7 papers
#4210$362
View Evidence →